← Back to Search

Spermatic Cord is isolated from the mesh for Inguinal Hernia

N/A

Waitlist Available

Led By John A Morrison, MD;FRCS(C)

Research Sponsored by Chatham Kent Health Alliance

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Clinical diagnosis of a primary unilateral inguinal hernia

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

There are in excess of 1 million operations performed annually to repair inguinal hernias, mostly in the male population. Unfortunately, some patients continue to suffer both groin or testicular pain for varying lengths of time postoperatively. This can lead to a severe degradation of the patient's lifestyle, work habits and sexual function. The origin of the pain is felt to be secondary to the inflammatory reaction caused by the mesh. This also involves the spermatic cord and its structures, leading to orchidinia and possibly azospermia.

Eligible Conditions

Inguinal Hernia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Evaluation of groin or testicular pain lasting longer than 3 months postoperatively.

Secondary outcome measures

Number of patients with adverse events.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Spermatic Cord is isolated from the meshExperimental Treatment1 Intervention

The inguinal ligament is interposed between the cord and the mesh and then repaired. This isolates the cord from the mesh and the splinting function of the overlying inguinal ligament.

Group II: Spermatic Cord in contact with meshActive Control1 Intervention

Where the spermatic cord has been allowed to remain in contact with the mesh.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Chatham Kent Health AllianceLead Sponsor

John A Morrison, MD;FRCS(C)Principal InvestigatorChatham Kent Health Alliance

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?

New York

What site did they apply to?

Chatham Kent Health Alliance

What portion of applicants met pre-screening criteria?

Met criteria

How many prior treatments have patients received?

Why did patients apply to this trial?

I put off surgery for a number of years, looking for alternatives, because of concerns about mesh. I looked to see if there were any new developments and found this trial.

PatientReceived 1 prior treatment